Cargando…
Current status of therapeutic monoclonal antibodies against SARS-CoV-2
Autores principales: | Kumar, Sanjeev, Chandele, Anmol, Sharma, Amit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415613/ https://www.ncbi.nlm.nih.gov/pubmed/34478455 http://dx.doi.org/10.1371/journal.ppat.1009885 |
Ejemplares similares
-
Correction: Current status of therapeutic monoclonal antibodies against SARS-CoV-2
por: Kumar, Sanjeev, et al.
Publicado: (2022) -
Profiles of host immune impairment in Plasmodium and SARS-CoV-2 infections
por: Chaturvedi, Rini, et al.
Publicado: (2022) -
Structural Profiles of SARS-CoV-2 Variants in India
por: Chakraborti, Soumyananda, et al.
Publicado: (2022) -
Broadly Neutralizing Antibodies to SARS-CoV-2 Provide Novel Insights Into the Neutralization of Variants and Other Human Coronaviruses
por: Bajpai, Prashant, et al.
Publicado: (2022) -
Airway models in a pandemic: Suitability of models in modeling SARS-CoV-2
por: Teo, Andrew, et al.
Publicado: (2022)